---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-24-000045"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2024-10-23T23:59:59+00:00"
generated_at: "2026-05-30T11:05:22.901069+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics grants stock options to CFO (427k shares) and controller (70k shares) at $3.44

## Summary
- Options to CFO Joseph Talamo cover 427,379 shares; to Principal Accounting Officer John Wesolowski cover 70,028 shares.
- Exercise price $3.44 per share, equal to fair market value on grant date (Oct 21, 2024).
- Options vest in five equal annual installments beginning on the grant date.
- Granted under the Company's 2021 Stock Incentive Plan.

## SEC filing metadata
- accession: 0001567264-24-000045
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2024-10-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000045/0001567264-24-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000045/intensity-20241021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-24-000045
- JSON: https://secwatch.observer/filing/0001567264-24-000045.json
- Plain text: https://secwatch.observer/filing/0001567264-24-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.